logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (vi) New inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates14.640.262.767.363.560.043.731.53479389
Cocaine4.28.38.47.06.08.74.65.4569157
Stimulants16.522.210.97.28.83.612.61.8122770
Hypnotics and sedatives3.31.92.54.58.516.923.045.0311110
Hallucinogens0.00.50.50.50.91.02.30.03843
Volatile substances5.12.91.61.11.10.01.10.919610
Cannabis 52.521.98.75.74.85.14.61.81570282
Other substances 4.02.24.76.76.34.68.013.5300197
Total1161339116537413511958711176901258
 

Notes:

Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012